Michael Gnant, MD, Medical University of Vienna

Articles by Michael Gnant, MD, Medical University of Vienna

Latest Updated Articles

Trending on OncLive

FDA Approves Denosumab Biosimilar for Skeletal-Related Events, GCTB, and Hypercalcemia of Malignancy

Daraxonrasib Approval Signals a New Era for RAS-Targeted Therapy in Pancreatic Cancer

CNS Control and Daily Tolerability Guide Treatment Sequencing in HER2-Mutated NSCLC

Tabelecleucel BLA Is Resubmitted to FDA for EBV+ Post-Transplant Lymphoproliferative Disease

FDA Grants Fast Track Designation to Plinabulin Plus Docetaxel in Post-ICI Non-Squamous NSCLC